Clinical implications of genotypic resistance to the newer antiretroviral drugs in HIV-1-infected patients with virological failure.
about
An antiretroviral/zinc combination gel provides 24 hours of complete protection against vaginal SHIV infection in macaquesEffectiveness of a Treatment Switch to Nevirapine plus Tenofovir and Emtricitabine (or Lamivudine) in Adults with HIV-1 Suppressed ViremiaEfficient identification of human immunodeficiency virus type 1 mutants resistant to a protease inhibitor by using a random mutant library.Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment.Microbial genomics and infectious diseases.The successful application of a national peer advisory committee for physicians who provide salvage regimens to heavily antiretroviral-experienced patients in mexican human immunodeficiency virus clinicsThe nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques.A cell-free enzymatic activity assay for the evaluation of HIV-1 drug resistance to protease inhibitors.Cost analysis of HIV treatment and drug-related adverse events when fixed-dose combinations of antiretrovirals (FDCs) were stopped, versus continuation with FDCsHIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance.Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics.Backbones versus core agents in initial ART regimens: one game, two players.Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda.Comparative Effectiveness of Darunavir 1,200 mg Daily and Approved Dosing Strategies for Protease Inhibitor-Experienced Patients.Withdrawing inactive NRTIs in HIV-1 subjects with suppressed viraemia: a randomized trial.Clinical and analytical relevance of NNRTIs minority mutations on viral failure in HIV-1 infected patients.HIV-1 protease mutations and protease inhibitor cross-resistance.Unplanned antiretroviral treatment interruptions, genetic barrier, and development of resistance.Genetic diversity and molecular epidemiology of HIV transmission
P2860
Q27438093-7F96554C-8E80-416E-BDBF-F37B5226D954Q28548630-CBC540DC-5FA2-4E9D-AD77-3691D9C570F1Q34005107-DA319BBF-FD86-4E1C-9488-9B4DC7B3D923Q34481372-02A54211-06AE-4A0C-8ECF-7A14CF25F911Q34631250-AD5B47A1-1423-47DB-93FD-35B88EC153B7Q34802051-9E62DF44-BDF2-45F3-AB5B-04D1CF9ECAF4Q34982693-9034F2D1-032C-473F-88B9-EF7E67A251F2Q36234463-81B5AD3E-4920-48D5-8FDB-473539C0352BQ36356572-0108F310-C824-403B-88B7-FDF7DE3C7EE8Q37913478-B1AD7291-516D-4A16-BD4C-3DE38848A23AQ38675771-A04639E3-D324-429B-B8AC-8DDD95A9CD1EQ38690825-E01CD370-9E8D-479C-A564-EEED7F9B247EQ38848190-9BA93261-4ADC-4225-A655-561F3249D061Q40131806-FAFF108E-BA73-4514-A9A9-4BDD53899B6CQ40820470-281718C2-0DB0-4712-A488-973CA67FF539Q42254682-AF495A0F-5700-4F50-B093-9D7DFE6A16FDQ42421248-DB5794A8-5CF0-4366-9BD4-16937A95E2FFQ51848341-6E028E3B-39AA-4144-9A62-4BD47FAECBCFQ57196807-CEEAE05B-4D2A-484B-85A9-5D5B929BE16F
P2860
Clinical implications of genotypic resistance to the newer antiretroviral drugs in HIV-1-infected patients with virological failure.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical implications of genot ...... ents with virological failure.
@en
Clinical implications of genot ...... ents with virological failure.
@nl
type
label
Clinical implications of genot ...... ents with virological failure.
@en
Clinical implications of genot ...... ents with virological failure.
@nl
prefLabel
Clinical implications of genot ...... ents with virological failure.
@en
Clinical implications of genot ...... ents with virological failure.
@nl
P921
P356
P1476
Clinical implications of genot ...... ents with virological failure.
@en
P2093
Jonathan M Schapiro
Josep M Llibre
P304
P356
10.1086/650732
P407
P577
2010-03-01T00:00:00Z